Regeneron (REGN) Tops Q3 EPS by 219c
Tweet
Share
E-mail
Get Alerts REGN Hot Sheet
Price: $614.98 +0.46%
EPS Growth %: -15.8%
Financial Fact:
Loss from operations: 362.8M
Today's EPS Names:
CRMT, MAYS, CRWS, More
EPS Growth %: -15.8%
Financial Fact:
Loss from operations: 362.8M
Today's EPS Names:
CRMT, MAYS, CRWS, More
Join SI Premium – FREE
Regeneron (NASDAQ: REGN) reported Q3 EPS of $11.83, $2.19 better than the analyst estimate of $9.64. Revenue for the quarter came in at $3.75 billion versus the consensus estimate of $3.59 billion.
For earnings history and earnings-related data on Regeneron (REGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SpaceX completes IPO at $135 per share, raising over $86 billion
- JPMorgan Upgrades CAMP4 Therapeutics Corp (CAMP) to Overweight
- Pharma-Bio Serv Announces Results for the Quarter Ended April 30, 2026
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
